Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Quality Changes Among Cancer Survivors Compared with Age at Cancer Diagnosis: Using the Korean National Health and Nutrition Examination Surveys (KNHANES 2019-2021).

Nutrients·2026
Same author

Pulmonary carcinogenic effects of subchronic inhalation exposure with long-term follow-up to polyhexamethylene guanidine phosphate in rats.

Scientific reports·2026
Same author

Management of Cravings and Relapse Risk in Patients With Alcohol Use Disorder in Korea: Analysis of Needs for Mobile Applications Based on Cognitive Behavioral Therapy.

Substance use & misuse·2026
Same author

Discovery of TCR-like antibodies to the KRAS G12D neoantigen via in silico-in vitro workflow.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

National Trends in Healthcare Quality in Korea: A Multidimensional Assessment Using OECD Health Care Quality Indicators (2008-2023).

Journal of preventive medicine and public health = Yebang Uihakhoe chi·2026
Same author

Difference in linear enamel hypoplasia frequency between the 16<sup>th</sup>- to 19<sup>th</sup>-century agrarian populations of the Korean Joseon dynasty and Siberian Russia.

Anthropological science : journal of the Anthropological Society of Nippon = Jinruigaku zasshi·2026

Related Experiment Video

Updated: Mar 17, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Type 2 high asthma phenotype in children: A multidimensional clustering analysis.

Soyoung Bae1, Hyejin Lee1

  • 1Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Asian Pacific Journal of Allergy and Immunology
|March 15, 2026
PubMed
Summary

This study identified three childhood asthma phenotypes using cluster analysis. A T2-high asthma cluster showed distinct immunological and clinical features, including high airway hyperresponsiveness and reduced lung function.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.8K

Related Experiment Videos

Last Updated: Mar 17, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.8K

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Computational Biology

Background:

  • Childhood asthma is a complex disease with poorly defined phenotypes.
  • Understanding these phenotypes is crucial for effective management.

Purpose of the Study:

  • To classify childhood asthma phenotypes using unsupervised clustering.
  • To analyze clinical characteristics and outcomes of identified phenotypes based on type 2 (T2) biomarkers.

Main Methods:

  • Retrospective analysis of 614 pediatric asthma patients.
  • Hierarchical clustering using age, absolute eosinophil count (AEC), eosinophil cationic protein (ECP), and total immunoglobulin E (IgE).
  • Comparison of clinical characteristics and 2-year outcomes across clusters, with age adjustment.

Main Results:

  • Three distinct asthma clusters were identified.
  • A T2-high cluster (Cluster 2) showed elevated T2 biomarkers, airway hyperresponsiveness, and reduced lung function.
  • Other clusters presented with high exacerbation rates (Cluster 1) or lower burden (Cluster 3), with varying T2 levels.

Conclusions:

  • A distinct T2-high phenotype in school-aged children with asthma was identified.
  • This phenotype is characterized by specific immunological profiles and clinical outcomes, including airway hyperresponsiveness and decreased lung function.